Safety and Efficacy of Varying Methods of ALV003 Administration for the Treatment of Celiac Disease
Clinical trial NCT01255696 · COMPLETED
Trial details
- NCT number
- NCT01255696
- Sponsor
- Alvine Pharmaceuticals Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-01
- Primary completion
- 2011-05-01
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.